Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Prostatic Neoplasms 24Neoplasms 4Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Sleep Apnea, Obstructive 1Recurrence 1Prostate Adenocarcinoma 1Premenopausal Breast Cancer 1Polycystic Ovary Syndrome 1Myeloproliferative Disorders 1Metabolic Syndrome 1Lymphoma, Mantle-Cell 1Leukemia, Myeloid, Acute 1Leiomyoma 1Insulin Resistance 1Glucose Intolerance 1Breast Neoplasms 1

Interventions

Cyclophosphamide 14fludarabine phosphate 12ruxolitinib 9Busulfan 9Antilymphocyte Serum 9Peripheral Blood Stem Cell Transplantation 8fludarabine 7Whole-Body Irradiation 7Filgrastim 7Cyclosporine 7Tacrolimus 6Radiotherapy 6Mycophenolic Acid 6Methylprednisolone 6Methotrexate 5Melphalan 5Cord Blood Stem Cell Transplantation 5Azacitidine 5Imatinib Mesylate 4Cytarabine 4Alemtuzumab 4ponatinib 3parsaclisib 3fedratinib 3Stem Cell Transplantation 3Rituximab 3Etoposide 3Decitabine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3venetoclax 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Myeloproliferative Disorders × Leuprolide × Clear all
NCT01343368 2017-12-05

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
19 enrolled 19 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡